About Centerline Biomedical
Centerline Biomedical is a private company based in Warrensville Heights, Ohio. It has reported $71,814,496 raised in four offerings on Form D since November 2023. Its chief executive is Gulam Khan.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 11, 2025 | Apr 25, 2025 | $10,784,000of $15.0M target | 8 | $1.3M | Equity, Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Feb 4, 2022 | Nov 3, 2023 | $34,675,000fully sold | 22 | $1.5M | EquityRule 506(b) | Form D ↗ |
| Aug 16, 2019 | Nov 3, 2023 | $12,705,496fully sold | 106 | $119K | EquityRule 506(b) | Form D ↗ |
| Aug 15, 2015 | Nov 3, 2023 | $13,650,000fully sold | 65 | $210K | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $71,814,496 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Centerline Biomedical's Form D filed Apr 25, 2025.
Earlier filings also listed Vinod Goel (executive officer, last listed Nov 2023), Vikash Goel (executive officer, last listed Nov 2023), Phil Rackliffe (executive officer and director, last listed Nov 2023), Karen Shanahan (director, last listed Nov 2023), Jim Zalar (director, last listed Nov 2023), Jai Gupta (director, last listed Nov 2023) and Akhil Saklecha (director, last listed Nov 2023).